(Q40707471)

22 September 2017

title

DDAVP in Von Willebrand's disease: Repeated administration and the behaviour of the bleeding time (English)

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

18 June 2022

main subject

von Willebrand's disease

1 reference

W. Theiss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A311959

18 June 2022

G. Schmidt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A311959

18 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=311959

18 June 2022

publication date

1 December 1978

1 reference

full work available at URL

22 September 2017

https://api.elsevier.com/content/article/PII:0049384878902402?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

https://api.elsevier.com/content/article/PII:0049384878902402?httpAccept=text/plain

18 June 2022

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

18 June 2022

1 reference

22 September 2017

volume

13

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

1119-1123

1 reference

Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs

22 September 2017

cites work

0 references

Studies on the prolonged bleeding time in von Willebrand's disease

3

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases

18 June 2022

4

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

D.D.A.V.P. in haemophilia

18 June 2022

5

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

D.D.A.V.P. in haemophilia

18 June 2022

6

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

DDAVP: alternative to replacement treatment in mild haemophilia A and von Willebrand-Jürgens syndrome (author's transl)

18 June 2022

7

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

D.D.A.V.P. in haemophilia

18 June 2022

8

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate

18 June 2022

10

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies

18 June 2022

13

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

Effect of exercise on F VIII-complex: Proportional increase of ristocetin cofactor (von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF

18 June 2022

15

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90240-2

18 June 2022

Identifiers

1 reference

22 September 2017

1 reference